Status:
COMPLETED
A Prospective "Universal" Observational Database for COVID-19
Lead Sponsor:
Hackensack Meridian Health
Conditions:
COVID-19
Eligibility:
All Genders
Brief Summary
The Hackensack Meridian Health Universal Observational COVID-19, a descriptive observational database, is a multi-center initiative collecting data throughout the Hackensack Meridian Health Network (H...
Detailed Description
The principle objective of this observational database is to build research-grade real world data that will serve as platform to advance the scientific understanding and clinical care of patients with...
Eligibility Criteria
Inclusion
- Confirmed or suspected COVID-19
- Data available via the EPIC system
- NO age restriction
- NO pregnancy restrictions
Exclusion
- Patients on a clinical trial in which the treatment is blinded may be included in the database, however the study medication or treatment will be noted as "experimental" and not reported individually. NO efforts to "break" randomization or blinding will be permitted
- Patients may refuse to be tracked in the database and/or participate in this observational study. Given the lack of active "study" procedures in this observational database, formal informed consent is not required
Key Trial Info
Start Date :
March 27 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 12 2023
Estimated Enrollment :
4588 Patients enrolled
Trial Details
Trial ID
NCT04347993
Start Date
March 27 2020
End Date
June 12 2023
Last Update
September 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hackensack Meridian Health - John Theurer Cancer Center
Hackensack, New Jersey, United States, 07601